Samlyn Capital’s Inozyme Pharma INZY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-3,259,158
| Closed | -$17M | – | 99 |
|
|
2024
Q3 | $17M | Sell |
3,259,158
-91,377
| -3% | -$478K | 0.26% | 70 |
|
|
2024
Q2 | $14.9M | Buy |
3,350,535
+437,622
| +15% | +$1.95M | 0.25% | 77 |
|
|
2024
Q1 | $22.3M | Sell |
2,912,913
-459,645
| -14% | -$3.52M | 0.37% | 69 |
|
|
2023
Q4 | $14.4M | Buy |
3,372,558
+127,350
| +4% | +$543K | 0.29% | 63 |
|
|
2023
Q3 | $13.6M | Buy |
+3,245,208
| New | +$13.6M | 0.22% | 75 |
|